Abstract
Specific mixtures of prebiotic oligosaccharides showed immune modulatory effects in previous murine vaccination experiments, suggesting a shift towards T-helper 1 (Th1) immunity. These mixtures consisted of short-chain galacto-oligosaccharides (scGOS) and long-chain fructo-oligosaccharides (lcFOS) in a 9:1 ratio (Immunofortis), with or without pectin-derived acidic oligosaccharides (pAOS). To investigate whether these mixtures could suppress Th2-related responses, they were tested in an ovalbumin (OVA)-induced model for experimental allergic asthma in BALB/c mice. Supplementation with two mixtures of scGOS/lcFOS and scGOS/lcFOS/pAOS at approximately 1% (w/w% net oligosaccharides) in the diet, starting two weeks before OVA sensitization and lasting until the end of the experiment, decreased of several parameters of allergic asthma. The OVA-induced airway inflammation and hyperresponsiveness was significantly suppressed by both mixtures. Moreover, OVA-specific IgE titers were decreased by more than 25%, although this effect was not significant. The effects of the oligosaccharide mixture with pAOS appeared to be more pronounced than the effects of the scGOS/lcFOS mixture without pAOS, but a direct comparison between the mixtures was not made. Overall, the results further support the hypothesis that specific mixtures of oligosaccharides modulate the Th1/Th2 balance by enhancing Th1-related and suppressing Th2-related parameters. © 2007 Elsevier B.V. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 1582-1587 |
Number of pages | 6 |
Journal | International Immunopharmacology |
Volume | 7 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2007 |
Keywords
- Acidic oligosaccharides
- Allergy
- Asthma
- Immune modulation
- Prebiotics
- fructose oligosaccharide plus galactose oligosaccharide
- immunofortis
- immunoglobulin E
- oligosaccharide
- ovalbumin
- prebiotic agent
- unclassified drug
- allergic asthma
- animal experiment
- animal model
- article
- controlled study
- diet supplementation
- drug mechanism
- immunomodulation
- lung lavage
- male
- mouse
- nonhuman
- priority journal
- Th1 cell
- Th2 cell